BioMarin Pharmaceutical, Inc. (BMRN)
54.69
-0.20
(-0.36%)
USD |
NASDAQ |
Oct 09, 11:35
BioMarin Pharmaceutical 30-Day Average Daily Volume : 2.072M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 2.072M |
| October 07, 2026 | 2.031M |
| October 06, 2026 | 2.007M |
| October 05, 2026 | 1.959M |
| October 02, 2026 | 1.932M |
| October 01, 2026 | 1.901M |
| September 30, 2026 | 1.898M |
| September 29, 2026 | 1.903M |
| September 28, 2026 | 1.917M |
| September 25, 2026 | 1.885M |
| September 24, 2026 | 1.903M |
| September 23, 2026 | 1.942M |
| September 22, 2026 | 2.004M |
| September 21, 2026 | 2.107M |
| September 18, 2026 | 2.190M |
| September 17, 2026 | 2.156M |
| September 16, 2026 | 2.166M |
| September 15, 2026 | 2.133M |
| September 14, 2026 | 2.132M |
| September 11, 2026 | 2.167M |
| September 10, 2026 | 2.154M |
| September 09, 2026 | 2.141M |
| September 08, 2026 | 2.141M |
| September 04, 2026 | 2.147M |
| September 03, 2026 | 2.135M |
| Date | Value |
|---|---|
| September 02, 2026 | 2.169M |
| September 01, 2026 | 2.132M |
| August 31, 2026 | 2.127M |
| August 28, 2026 | 2.090M |
| August 27, 2026 | 2.107M |
| August 26, 2026 | 2.108M |
| August 25, 2026 | 2.076M |
| August 24, 2026 | 2.077M |
| August 21, 2026 | 2.054M |
| August 20, 2026 | 2.053M |
| August 19, 2026 | 2.042M |
| August 18, 2026 | 2.028M |
| August 17, 2026 | 2.016M |
| August 14, 2026 | 2.001M |
| August 13, 2026 | 2.004M |
| August 12, 2026 | 1.976M |
| August 11, 2026 | 1.938M |
| August 10, 2026 | 1.866M |
| August 07, 2026 | 1.822M |
| August 06, 2026 | 1.766M |
| August 05, 2026 | 1.704M |
| August 04, 2026 | 1.716M |
| August 03, 2026 | 1.775M |
| July 31, 2026 | 1.829M |
| July 30, 2026 | 1.808M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.503M |
| Vertex Pharmaceuticals, Inc. | 1.013M |
| Ascendis Pharma A/S | 845261.7 |
| BridgeBio Pharma, Inc. | 2.697M |
| Incyte Corp. | 1.595M |